comparemela.com
Home
Live Updates
Test Lp(a) Levels to Inform ASCVD Management: NLA Statement : comparemela.com
Test Lp(a) Levels to Inform ASCVD Management: NLA Statement
Individuals at risk for atherosclerotic cardiovascular disease should have lipoprotein(a) levels tested to help guide primary and secondary prevention strategies, says the National Lipid Association.
Related Keywords
Italy ,
Milan ,
Lombardia ,
United States ,
Fort Worth ,
Texas ,
American ,
Donp Wilson ,
Albericol Catapano ,
,
European Society Of Cardiology Congress ,
Department Of Pediatric Endocrinology ,
Cook Children Medical Center ,
National Lipid Association ,
European Atherosclerosis Society ,
University Of Milan ,
Akcea Therapeutics Ionis Pharmaceuticals ,
Clinical Lipidology ,
Pediatric Endocrinology ,
Cook Children ,
Medical Center ,
Medscape Cardiology ,
European Society ,
Cardiology Congress ,
European Heart ,
Patient Centered Management ,
African American ,
Silence Therapeutics ,
Ionis Pharmaceuticals ,
South Asians ,
Lipids ,
Ipid Management ,
Acute Coronary Syndrome Acs ,
Cute Coronary Syndrome ,
Cs ,
Atherosclerotic Heart Disease ,
Therosclerotic Cardiovascular Disease ,
Oronary Heart Disease ,
Schemic Heart Disease ,
Coronary Atherosclerosis ,
Atherosclerosis ,
Cv ,
Ardiovascular ,
Diabetes Mellitus ,
Hypercholesterolemia ,
Myocardial Infarction ,
Stroke ,
Erebrovascular Accident ,
Va Cerebrovascular Accident ,
Heart Failu ,
comparemela.com © 2020. All Rights Reserved.